Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,359.68
(
-0.14%
)
US TECH 100
22,454.31
(
-0.22%
)
Dow Jones
45,313.31
(
0.32%
)
Brent Oil
107.66
(
-0.55%
)
Bitcoin
66,867.90
(
1.38%
)
News Focus
News Focus
Post# of 257308
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122821
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 113057

Tuesday, 03/19/2013 9:20:05 PM

Tuesday, March 19, 2013 9:20:05 PM

Post# of 257308

AMGN acquisition of Biovex is quite high risk in my opinion. It is either genius or dumb move.

The former BioVex owners must be celebrating today insofar as their chances of earning $575M in regulatory and sales milestones just went up.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up